When used as directed, penile traction devices can be a beneficial tool for patients with Peyronie’s disease. Researchers from the Urology Department at University Hospitals in Madrid have successfully used collagenase from Clostridium histolyticum (CCH) to treat patients with this disease. Patients were required to use the Penis Traction Device for at least four hours a day.

Penile traction therapy

A new therapeutic option for Peyronie’s disease is penile traction therapy (PTT). This method of stretching and reshaping the penis is similar to those used in other areas of medicine, such as orthopedics. Continuously extending the fibrous plaque results in significant increases in collagenase and metalloproteinase activity, leading to softening and extension. Clinical studies have shown promising results with PTT for PD.

In one study, the use of a penile traction device was evaluated in men with the acute phase of PD. The treatment group included 55 men undergoing PTT, compared to 41 men who were not treated with active therapy. The PTT group showed significant reductions in penile curvature at 6 and 9 months, and erectile function scores improved significantly. Furthermore, the patients undergoing PTT experienced significant improvements in erection hardness and erectile function, with an increase in SPL of 1 to 4 cm.

Patients suffering from the disease can benefit from an injection medication, which reduces the bending and pain of the penis. Collagenase is an FDA-approved treatment for patients with moderate to severe curvatures and nodules. This treatment may help relieve the pain associated with Peyronie’s disease. Nevertheless, patients should be under the care of a medical professional to ensure safety.

Mechanisms of Peyronie’s disease

While the exact cause of Peyronie’s disease is not fully understood, some researchers suspect that the penis forms a scar after being injured or bent abnormally. While 80% of men do not recall a specific incident that led to the penile changes, these changes are likely the result of minor injuries sustained during regular sexual relations. Those men with peyronie’s disease are at an increased risk for too much scar tissue to form.

Although the etiological cause of Peyronie’s disease is now better understood, therapeutic options remain inadequate. Although several treatments have been developed, none of them has been proven to be superior to surgery. Surgery remains the primary treatment for chronic, stable disease, with the goal of straightening the penis and restoring penetrative coital activity. However, surgery can cause serious complications and should only be considered in selected cases.

Effects of Penile Traction Devices on Peyronie’s disease

The Effects of Penile Traction Devices On Peyronie’s Disease

Penile traction is a relatively new therapy for Peyronie’s disease. Although a long-established form of treatment in other fields of medicine, this method is a relatively new option for PD. Penile traction devices cause gradual expansion of tissue, resulting in the formation of new collagen tissue. Additionally, continuous extension of fibrous plaques leads to significant increases in collagenase and metalloproteinases, resulting in softening and extension. Clinical studies have demonstrated promising results in PD patients.

Among all the treatments for Peyronie’s disease, penile traction therapy is the only conservative treatment method that reliably improves penile length. In one study, 55 men with Peyronie’s disease were enrolled and made to wear a penile traction device for 4.6 hours daily for six months. After this time, the patients’ penile curvature decreased by up to 20 degrees and other symptoms also improved.

Legitimacy of penile traction therapy device

A recent study evaluated the role of a vacuum pump therapy in the treatment of patients with Peyronie’s disease. Researchers examined the combination of penile traction with intralesional verapamil and oral agents. The authors also assessed patient-partner satisfaction with the therapy. These findings show that the vacuum pump therapy improves erectile function and reduces pain associated with the disease.

The RestoreX device was initially developed for men with a curvature in the penis caused by Peyronie’s disease. The device applies gentle dynamic pressure to stretch and shape the penis. Results show a significant straightening of peniles with 30 minutes a day use, as opposed to the several hours a previous PTT device required.

One study found that a penile traction therapy device could increase penile length and curvature by 17 degrees in men with PD. However, the study also found that the improvement in penile length was modest, with 29% of responders achieving 2-cm gains in length. While the device was associated with minor adverse effects, these were transient and did not prevent patients from completing therapy.